Co‐formulated abacavir‐lamivudine‐zidovudine vs NNRTIs or PIs
Virologic suppression Viral load < 50 copies/ml · patients with initial treatment of HIV infection in antiretroviral‐naive individuals
Co‐formulated abacavir‐lamivudine‐zidovudine showed no clear difference in virologic suppression Viral load < 50 copies/ml compared with NNRTIs or PIs (moderate certainty).
1 finding from 1 review
- Co‐formulated abacavir‐lamivudine‐zidovudine for initial treatment of HIV infection and AIDS 2013 · Cochrane Headline outcomes onlyRR 0.97 [0.75, 1.25]4 studies · 2247 participantsModerate